Anchen Pharmaceuticals Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 2,018
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 1

Anchen Pharmaceuticals General Information

Description

Manufacturer of pharmaceutical products. The company primarily focused on the development and commercialization of extended release generic products primarily for patients in the United States.

Contact Information

Website
www.anchen.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 9601 Jeronimo
  • Irvine, CA 92618
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anchen Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anchen Pharmaceuticals‘s full profile, request access.

Request a free trial

Anchen Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anchen Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000000000 01-Jan-2006 000000000000000000 Drug Discovery 0000-0000 0000 00.0
To view Anchen Pharmaceuticals’s complete acquisitions history, request access »

Anchen Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 00000000000000 01-Jan-2006 000000000000000000 Completed
  • 000000 00000000000
To view Anchen Pharmaceuticals’s complete exits history, request access »